Articles with public access mandates - Murali RamanathanLearn more
Not available anywhere: 27
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis
N Kappus, B Weinstock-Guttman, J Hagemeier, C Kennedy, R Melia, ...
Journal of Neurology, Neurosurgery & Psychiatry 87 (2), 181-187, 2016
Mandates: US National Science Foundation, US National Institutes of Health
Vitamin D metabolites are associated with clinical and MRI outcomes in multiple sclerosis patients
B Weinstock-Guttman, R Zivadinov, J Qu, D Cookfair, X Duan, E Bang, ...
Journal of Neurology, Neurosurgery & Psychiatry 82 (2), 189-195, 2011
Mandates: US National Institutes of Health
Ultrasensitive quantification of serum vitamin D metabolites using selective solid-phase extraction coupled to microflow liquid chromatography and isotope-dilution mass …
X Duan, B Weinstock-Guttman, H Wang, E Bang, J Li, M Ramanathan, ...
Analytical chemistry 82 (6), 2488-2497, 2010
Mandates: US National Institutes of Health
Identification of information flow‐modulating drug targets: a novel bridging paradigm for drug discovery
WC Hwang, A Zhang, M Ramanathan
Clinical Pharmacology & Therapeutics 84 (5), 563-572, 2008
Mandates: US National Institutes of Health
Comparison of the immunomodulatory effects of the plant sterol β-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients
F Desai, M Ramanathan, CS Fink, GE Wilding, B Weinstock-Guttman, ...
International immunopharmacology 9 (1), 153-157, 2009
Mandates: US National Institutes of Health
Lifestyle-based modifiable risk factors in multiple sclerosis: review of experimental and clinical findings
D Jakimovski, Y Guan, M Ramanathan, B Weinstock-Guttman, ...
Neurodegenerative disease management 9 (3), 149-172, 2019
Mandates: US National Science Foundation, US Department of Defense, US National …
Mechanisms of interferon-β effects on bone homeostasis
AK Abraham, M Ramanathan, B Weinstock-Guttman, DE Mager
Biochemical pharmacology 77 (12), 1757-1762, 2009
Mandates: US National Institutes of Health
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
S Gupta, R Zivadinov, M Ramanathan, B Weinstock-Guttman
Expert review of neurotherapeutics 16 (7), 765-775, 2016
Mandates: US National Science Foundation
Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study
D Jakimovski, B Weinstock-Guttman, S Gandhi, Y Guan, J Hagemeier, ...
Journal of neurology 266, 866-875, 2019
Mandates: US National Institutes of Health
Cholesterol and neurodegeneration: longitudinal changes in serum cholesterol biomarkers are associated with new lesions and gray matter atrophy in multiple sclerosis over 5 …
N Murali, RW Browne, K Fellows Maxwell, ML Bodziak, D Jakimovski, ...
European Journal of Neurology 27 (1), 188-e4, 2020
Mandates: US National Institutes of Health
Ocrelizumab: a B-cell depleting therapy for multiple sclerosis
D Jakimovski, B Weinstock-Guttman, M Ramanathan, C Kolb, D Hojnacki, ...
Expert opinion on biological therapy 17 (9), 1163-1172, 2017
Mandates: US National Science Foundation, US Department of Defense, US National …
Vitamin D and multiple sclerosis
B Weinstock-Guttman, BK Mehta, M Ramanathan, Y Karmon, LJ Henson, ...
The neurologist 18 (4), 179-183, 2012
Mandates: US National Institutes of Health
Patterns of dietary and herbal supplement use by multiple sclerosis patients
K O’Connor, B Weinstock-Guttman, E Carl, C Kilanowski, R Zivadinov, ...
Journal of neurology 259, 637-644, 2012
Mandates: US National Institutes of Health
Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis
B Weinstock-Guttman, R Zivadinov, M Ramanathan
Journal of the neurological sciences 311 (1-2), 86-91, 2011
Mandates: US National Institutes of Health
Retinal nerve fiber layer thickness and thalamus pathology in multiple sclerosis patients
R Zivadinov, N Bergsland, R Cappellani, J Hagemeier, R Melia, E Carl, ...
European journal of neurology 21 (8), 1137-e61, 2014
Mandates: US National Institutes of Health
The rs2030324 SNP of brain-derived neurotrophic factor (BDNF) is associated with visual cognitive processing in multiple sclerosis
B Weinstock-Guttman, RHB Benedict, M Tamaño-Blanco, DP Ramasamy, ...
Pathophysiology 18 (1), 43-52, 2011
Mandates: US National Institutes of Health
Generalized pharmacometric modeling, a novel paradigm for integrating machine learning algorithms: a case study of metabolomic biomarkers
M McComb, M Ramanathan
Clinical Pharmacology & Therapeutics 107 (6), 1343-1351, 2020
Mandates: US National Science Foundation, US National Institutes of Health
A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis
E Tavazzi, N Bergsland, J Kuhle, D Jakimovski, M Ramanathan, ...
Journal of neurology 267, 802-811, 2020
Mandates: Swiss National Science Foundation
Advances in therapy, imaging and risk factors in MS
B Weinstock–Guttman, M Ramanathan
Nature Reviews Neurology 8 (2), 66-68, 2012
Mandates: US National Institutes of Health
Application of Brunauer–Emmett–Teller (BET) theory and the Guggenheim–Anderson–de Boer (GAB) equation for concentration-dependent, non-saturable cell–cell interaction dose …
VA Nguyen, M Ramanathan
Journal of Pharmacokinetics and Pharmacodynamics 47, 561-572, 2020
Mandates: US Department of Defense, US National Institutes of Health
Publication and funding information is determined automatically by a computer program